Immunotherapy;Envafolimab; Esophageal Cancer
1 clinical trials · Condition
◉ Watch Immunotherapy;Envafolimab; Esophageal Cancer
| Record | Firm | Date |
|---|---|---|
| Envafolimab Combined With Abraxane and Cisplatinas as Neoadjuvant Treatment for Resectable Esophageal Cancer (NCT05828381) | Fujian Medical University Union Hospital | 2023-06-01 |
Track Immunotherapy;Envafolimab; Esophageal Cancer automatically
Every clearance here is in the API, with alerts when new ones post.